Showing 1 posts of 1 posts found.
AstraZeneca have completed a third sell off in the course of one week by divesting rights to Rhinocort Aqua outside …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement